跳至主要内容
临床试验/CTRI/2010/091/000190
CTRI/2010/091/000190招募中未知

Imatinib pharmacokinetics and its correlation with response and safety in Indian children and adults with chronic phase chronic myeloid leukemia.

Terry Fox Fooundation0 个研究点目标入组 150 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Ba/be

入排标准

入选标准

  • 1.Patients diagnosed with chronic phase CML.
  • 2.Willing to consent for the study.
  • 3.Able to recieve imatinib for atleast 24 months.

排除标准

  • 1.Blood collection performed out of the trough concentration time limits.
  • 2.Poor compliance to treatment.
  • 3.Consumed grapefruit or grape fruit products less than one week before sample collection for pharmacokinetics.
  • 4.Consumed a CYP3A4 enzyme inducer or inhibitor or a p-glycoprotein substrate less than 14 days prior to pharmacokinetic blood draw.

研究者

发起方
Terry Fox Fooundation

相似试验

已完成
不适用
Imatinib pharmacokinetics and its correlation with response in chronic-phase chronic myelogenous leukemiachronic myelogenous leukemia in chronic-phase
JPRN-UMIN000001125Keio University School of Medicine60
已完成
4 期
Population Pharmacokinetics study of ImatinibChronic myeloid leukaemia (CML).Chronic myeloid leukaemia [CML], BCR/ABL-positive
IRCT2014050612206N1Kerman University of Medical Sciences220
进行中(未招募)
不适用
An exploratory study of the effects of Imatinib on allergic inflammation following out of allergy season repeated nasal allergen challenge in subjects with seasonal allergic rhinitis sensitive to Timothy grass pollen – an exploratory study of c-kit inhibition in allergic respiratory diseasesSeasonal Allergic Rhinitis (sensitivity to Timothy grass pollen)MedDRA version: 8.1Level: LLTClassification code 10039776Term: Seasonal allergic rhinitis
EUCTR2006-004722-82-GBovartis Pharma Services AG30
已完成
不适用
A Randomized Phase Lll Study of Imatinib Dose Optimization Compared With Nilotinib in Patients With Chronic Myelogenous Leukemia and Suboptimal Response to Standard-dose Imatinib
PER-023-09OVARTIS BIOSCIENSES PERU S.A.,
进行中(未招募)
不适用
The degradation and elimination of InfliximabInflammatory bowel disease (Ulcerative Colitis, Crohn's disease)MedDRA version: 17.0Level: PTClassification code 10011401Term: Crohn's diseaseSystem Organ Class: 10017947 - Gastrointestinal disordersMedDRA version: 17.0Level: LLTClassification code 10045365Term: Ulcerative colitisSystem Organ Class: 10017947 - Gastrointestinal disorders
EUCTR2011-001332-29-ATniversitätsklinik für Innere Medizin III, Klinische Abteilung für Gastroenterologie und Hepatologie